Cognitive Impairment Associated With Schizophrenia Cias clinical trials

Explore recruiting cognitive impairment associated with schizophrenia cias clinical trials.

Recruiting cognitive impairment associated with schizophrenia cias studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cognitive Impairment Associated With Schizophrenia Cias trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An adaptive, randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of RL-007 in the treatment of cognitive impairment associated with schizophrenia (CIAS)

Poland, Bulgaria, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

"A double blind, randomized, placebo-controlled, adaptive 24-week Phase II trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia" (EVOLUTION STUDY)

Spain, Bulgaria, Romania, Poland, Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

Cognitive Impairment Associated With Schizophrenia Cias trials by city

Cognitive Impairment Associated With Schizophrenia Cias in Toronto Cognitive Impairment Associated With Schizophrenia Cias in Vancouver Cognitive Impairment Associated With Schizophrenia Cias in Montreal Cognitive Impairment Associated With Schizophrenia Cias in Calgary Cognitive Impairment Associated With Schizophrenia Cias in Edmonton Cognitive Impairment Associated With Schizophrenia Cias in Ottawa Cognitive Impairment Associated With Schizophrenia Cias in Winnipeg Cognitive Impairment Associated With Schizophrenia Cias in Quebec City Cognitive Impairment Associated With Schizophrenia Cias in Hamilton Cognitive Impairment Associated With Schizophrenia Cias in Kitchener Cognitive Impairment Associated With Schizophrenia Cias in London Cognitive Impairment Associated With Schizophrenia Cias in Halifax Cognitive Impairment Associated With Schizophrenia Cias in New York Cognitive Impairment Associated With Schizophrenia Cias in Los Angeles Cognitive Impairment Associated With Schizophrenia Cias in Chicago Cognitive Impairment Associated With Schizophrenia Cias in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease